Browse > Article
http://dx.doi.org/10.7853/kjvs.2013.36.1.15

Development of antibodies after foot and mouth disease vaccination in pigs  

Ahn, Gil-Ho (Gyeonggi Province Northern Livestock and Veterinary Service)
Bae, Jin-Gyu (Gyeonggi Province Veterinary Service Center)
Jung, Kwang (Gyeonggi Province Northern Livestock and Veterinary Service)
Wang, Young-Il (Korea Pork Producer Association)
Jung, Jun-Yong (Gyeonggi Province Northern Livestock and Veterinary Service)
Kang, Soon-Keun (Gyeonggi Province Northern Livestock and Veterinary Service)
Kwon, Hyuk-Moo (College of Veterinary Medicine, Kangwon National University)
Publication Information
Korean Journal of Veterinary Service / v.36, no.1, 2013 , pp. 15-21 More about this Journal
Abstract
Three serotypes (O+A+Asia1 type) of the foot-and-mouth disease (FMD) vaccine were injected into cloven-hoofed animals in Korea after the nationwide spread of FMD at the end of 2010. This study was conducted to investigate FMD antibody development after FMD vaccination, and to determine whether there was a significant correlation between the antibody titer of the sow and the antibody titer of the growing pigs. The antibody titer (percentage inhibition [PI] titer) of the sow (gilt) after FMD vaccination was maintained at a level higher than 50 (P<0.05) for 5 months. A higher PI titer for the 1-month-old growing pigs corresponded with greater inhibition of the PI titer of the vaccinated growing pigs (P<0.05). A negative correlation (P<0.05) between the PI titer of the 1-month-old growing pigs and the PI titer of 3-month-old growing pigs, 4-month-old growing pigs after FMD vaccination at 2 months, 3months was identified, with a coefficient of determination ($R^2$) of 0.274. Thus the PI titer of the growing pigs was inhibited to a greater degree when vaccination was performed at 2 months of age than at 3 months. However, many other factors likely influence growing pigs' PI titer in addition to the PI titer of the sow and age at vaccination, given that the coefficient of determination was somewhat lower.
Keywords
Foot and mouth disease; Cloven-hoofed animal; Vaccination; Percentage inhibition (PI) titer;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Paton DJ, Valarcher JF, Bergmann I, Matlho OG, Zakharov VM, Palma EL, Thomson GR. 2005. Selection of foot-andmouth disease vaccine strains-a review. Rev Sci Tech 24: 981-993.   DOI
2 Pattnaik B, Subramaniam S. Sanyal A, Mohapatra JK, Dash BB, Ranjan R, Rout M. 2012. Foot-and-mouth disease: Global status and future road map for control and prevention in India. Agricultural Research 1: 132-147.   DOI
3 Paul S, Simon SB, Raul CO, Keith JS. 2003. Control and eradication of foot-and-mouth disease. Virus Res 91: 101-144.   DOI   ScienceOn
4 Pay TW, Hingley PJ. 1986. The use of serum neutralizing antibody assay for the determination of the potency of foot-and-mouth disease(FMD) vaccines in cattle. Dev Biol Stand 64: 153-161.
5 Pfaff E, Mussgay M, Bӧhm HO, Schulz GE, Schaller H. 1982. Antibodies against a preselected peptide recognise and neutralise foot and mouth disease virus. EMBO J 1: 869-874.
6 Rea LM, Parker RA. 2005. Designing & Conducting Survey Research A Comprehensive Guide. 3rd ed. Jossey-Bass, San Francisco.
7 Rodriguez LL, Grubman MJ. 2009. Foot and mouth disease virus vaccines. Vaccine 27: D90-94.   DOI   ScienceOn
8 Rowlands DJ, Sangar DV, Brown F. 1971. Relationship of the antigenic structure of foot-and-mouth disease virus to the process of infection. J Gen Virol 13: 85-93.   DOI   ScienceOn
9 Saiz M, Nunez JI, Jimenez-Clavero MA, Baranowski E, Sobrino F. 2002. Foot-and-mouth disease virus: biology and prospects for disease control. Microbes Infect 4: 1183-1192.   DOI   ScienceOn
10 Sobrino F, Saiz M, Jimenez-Clavero MA, Nunez JI, Rosas MF, Baranowski E, Ley V. 2001. Foot and mouth disease: a long known virus, but a current threat. Vet Res 32: 1-30.   DOI   ScienceOn
11 Sur JH, Shin JH, Juan L, Max Y, Ku BK, Choi KS, Kweon BJ, Sohn HJ, Ko YJ, Choi CU, Kwon CH, Kim JY, An SH, Kim KS, Moon OK, Kim JH, Choi SH, Lee HG, Hwang EK, Kim SB, Kang SS, Kim OK. 2000. In vivo characterization and transmission of Korean foot-and-mouth disease virus(FMDV). Korean J Res 40: 719-727.
12 Wong HT, Cheng SCS, Chan EWC, Sheng ZT, Yan WY, Zheng ZX, Xie Y. 2000. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Virology 278: 27-35.   DOI   ScienceOn
13 Zhang L, Zhang J, Chen HT, Zhou JH, Ma LN, Ding YZ, Liu YS. 2011. Research in advance for FMD novel vaccines. Virol J 8: 268.   DOI
14 Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F. 1989. The three dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337: 709-16.   DOI   ScienceOn
15 Ayebazibwe C, Mwiine FN, Tjornehoj K, Balinda SN, Muwanika VB, Ademun OR, Belsham GJ, Normann P, Siegismund HR, Alexandersen S. 2010. The role of African buffalos(Suncerus caffer) in the maintenance of foot-and-mouth disease in Uganda. BMC Vet Res 6: 54.   DOI   ScienceOn
16 Belsham GJ. 1993. Distinctive features of foot and mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure, Prog Biophys Mol Biol 60: 241-260.   DOI   ScienceOn
17 Bruckner GK, Vosloo W, Cloete M, Dungu B, Du PBJ. 2004. Foot-and-mouth disease control using vaccination: South African experience. Dev Biol (Basel) 119: 51-62.
18 Callis JJ, McKercher PD, Graves JH. 1968. Foot and mouth dis-ease-a review. J Am Vet Med Assoc 153: 1798-1802.
19 Cox SJ, Barnett PV. 2009. Experimental evaluation of foot-andmouth disease vaccines for emergency use in ruminants and pigs: a review. Vet Res 40: 1-30.   DOI   ScienceOn
20 De Clercq K, Goris N, Barnett PV, Mackay DK. 2008. FMD Vaccines: reflections on quality aspects for applicability in European disease control policy. Transbound Emerg Dis 55: 46-56.   DOI   ScienceOn
21 Doel TR. 2003. FMD Vaccines. Virus Res 91: 81-99.   DOI   ScienceOn
22 Forman AJ, Garland AJM. 2002. Foot and mouth disease:the future of vaccine banks. Rev Sci Tech 21: 601-612.   DOI
23 Jones TC, Hunt RD, King NW. 1996. Disease caused by virus. pp. 271-273. In: Ringler DJ(ed.). Veterinary pathology. 6th ed. Williams & Wilkins Co, Maryland.
24 Kitching RP, Salt JS. 1995. The interference by maternally-derived antibody with active immunization of farm animals against foot-and-mouth disease. Br Vet J 151: 379-389.   DOI   ScienceOn
25 Laporte J. 1969. The structure of foot-and-mouth disease virus protein. J Gen Virol 4: 631-634.   DOI   ScienceOn
26 Leforban Y. 1999. Prevention measures against foot-and-mouth disease in Europe in recent years. Vaccine 17: 17551759.
27 Muleme M, Barigye R, Khaitsa ML, Berry E, Wamono AW, Ayebazibwe C. 2012. Effectiveness of vaccines and vaccination programs for the control of foot-and-mouth disease in Uganda, 2001-2010. Trop Anim Health Prod 45: 35-43.   DOI   ScienceOn
28 Mwiine FN, Ayebazibwe C, Olaho MW, Alexandersen S, Balinda SN, Masembe C, Okutut AR, Christensen LS, Sørensen KJ, Tjomehoj K. 2010. Serotype specificity of antibodies against foot-and-mouth disease virus in cattle in selected districts in Uganda. Transbound Emerg Dis 57: 365-374.   DOI   ScienceOn
29 Park JH, Lee KN, Kim SM, Ko YJ, Lee HS, Kweon CH, Yang CB. 2008. Molecular epidemiological analysis and recent distribution of foot-and-mouth disease in the world. Kor J Vet Publ Hlth 32: 61-68.   과학기술학회마을